Properties (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
nasal spray
|
| gptkbp:activeDuring |
gptkb:oxymetazoline
|
| gptkbp:administrativeDivision |
every 10 to 12 hours
|
| gptkbp:aroma |
none
|
| gptkbp:availableIn |
various formulations
over-the-counter medication various strengths children's formulations extra moisturizing options long-lasting options preservative-free options |
| gptkbp:brand |
gptkb:Afrin
|
| gptkbp:clinicalTrials |
studies on efficacy
studies on safety |
| gptkbp:colors |
clear
|
| gptkbp:contraindication |
diabetes
hypertension heart disease thyroid disorders |
| gptkbp:dosageForm |
liquid
|
| gptkbp:duration |
up to 12 hours
|
| gptkbp:expirationDate |
2 to 3 years
|
| gptkbp:formulation |
spray
|
| https://www.w3.org/2000/01/rdf-schema#label |
Afrin
|
| gptkbp:isRecognizedFor |
pregnant women
long-term use nursing mothers children under 6 years |
| gptkbp:lastProduced |
1980s
|
| gptkbp:mandates |
temporary relief of nasal congestion
|
| gptkbp:manufacturer |
gptkb:Schering-Plough
|
| gptkbp:marketedAs |
gptkb:Afrin_Original
gptkb:Afrin_No_Drip gptkb:Afrin_Severe_Congestion gptkb:Afrin_Extra_Moisturizing |
| gptkbp:packaging |
bottle
|
| gptkbp:relatedTo |
decongestants
adrenergic agonists sympathomimetics |
| gptkbp:route |
nasal
|
| gptkbp:sideEffect |
nasal congestion
sneezing nasal irritation dryness of the nasal mucosa |
| gptkbp:storage |
room temperature
|
| gptkbp:suitableFor |
2 to 3 sprays per nostril
|
| gptkbp:trimLevels |
approximately 5.0 to 6.0
|
| gptkbp:type |
gptkb:oxymetazoline_hydrochloride
|
| gptkbp:usedFor |
nasal congestion
|